HDL dysfunction in diabetes: causes and possible treatments
- 1 March 2012
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Review of Cardiovascular Therapy
- Vol. 10 (3), 353-361
- https://doi.org/10.1586/erc.11.182
Abstract
HDL is known to be inversely correlated with cardiovascular disease due to its diverse antiatherogenic functions. These functions include cholesterol efflux and reverse cholesterol transport, antioxidative and anti-inflammatory activities. However, HDL has been shown to undergo a loss of function in several pathophysiological states, as in the acute phase response, obesity and chronic inflammatory diseases. Some of these diseases were also shown to be associated with increased risk for cardiovascular disease. One such disease that is associated with HDL dysfunction and accelerated atherosclerosis is diabetes mellitus, a disease in which the HDL particle undergoes diverse structural modifications that result in significant changes in its function. This review will summarize the changes that occur in HDL in diabetes mellitus and how these changes lead to HDL dysfunction. Possible treatments for HDL dysfunction are also briefly described.Keywords
This publication has 103 references indexed in Scilit:
- Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotypeAtherosclerosis, 2011
- Serum Amyloid A Facilitates the Binding of High-Density Lipoprotein From Mice Injected With Lipopolysaccharide to Vascular ProteoglycansArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- High-Density Lipoprotein Suppresses the Type I Interferon Response, a Family of Potent Antiviral Immunoregulators, in Macrophages Challenged With LipopolysaccharideCirculation, 2010
- Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-IArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Structure and Function of HDL MimeticsArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Separating the Mechanism-Based and Off-Target Actions of Cholesteryl Ester Transfer Protein Inhibitors With CETP Gene PolymorphismsCirculation, 2010
- Hemoglobin and Its Scavenger Protein Haptoglobin Associate with ApoA-1-containing Particles and Influence the Inflammatory Properties and Function of High Density LipoproteinOnline Journal of Public Health Informatics, 2009
- Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-IProceedings of the National Academy of Sciences of the United States of America, 2008
- General Cardiovascular Risk Profile for Use in Primary CareCirculation, 2008
- Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDLJCI Insight, 2007